1. Home
  2. NVAX vs VYX Comparison

NVAX vs VYX Comparison

Compare NVAX & VYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVAX
  • VYX
  • Stock Information
  • Founded
  • NVAX 1987
  • VYX 1881
  • Country
  • NVAX United States
  • VYX United States
  • Employees
  • NVAX N/A
  • VYX N/A
  • Industry
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • VYX
  • Sector
  • NVAX Health Care
  • VYX
  • Exchange
  • NVAX Nasdaq
  • VYX Nasdaq
  • Market Cap
  • NVAX 1.3B
  • VYX 1.5B
  • IPO Year
  • NVAX 1995
  • VYX N/A
  • Fundamental
  • Price
  • NVAX $8.17
  • VYX $9.56
  • Analyst Decision
  • NVAX Buy
  • VYX Strong Buy
  • Analyst Count
  • NVAX 6
  • VYX 7
  • Target Price
  • NVAX $17.83
  • VYX $15.50
  • AVG Volume (30 Days)
  • NVAX 4.7M
  • VYX 2.2M
  • Earning Date
  • NVAX 05-09-2025
  • VYX 05-08-2025
  • Dividend Yield
  • NVAX N/A
  • VYX N/A
  • EPS Growth
  • NVAX N/A
  • VYX N/A
  • EPS
  • NVAX N/A
  • VYX 6.52
  • Revenue
  • NVAX $682,162,000.00
  • VYX $2,826,000,000.00
  • Revenue This Year
  • NVAX N/A
  • VYX N/A
  • Revenue Next Year
  • NVAX $15.02
  • VYX N/A
  • P/E Ratio
  • NVAX N/A
  • VYX $1.47
  • Revenue Growth
  • NVAX N/A
  • VYX N/A
  • 52 Week Low
  • NVAX $3.81
  • VYX $9.53
  • 52 Week High
  • NVAX $23.86
  • VYX $15.34
  • Technical
  • Relative Strength Index (RSI)
  • NVAX 51.30
  • VYX 23.73
  • Support Level
  • NVAX $7.66
  • VYX $10.30
  • Resistance Level
  • NVAX $8.48
  • VYX $10.94
  • Average True Range (ATR)
  • NVAX 0.64
  • VYX 0.57
  • MACD
  • NVAX 0.08
  • VYX -0.14
  • Stochastic Oscillator
  • NVAX 71.43
  • VYX 0.49

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

About VYX NCR Voyix Corporation

NCR Voyix Corp is a company providing services of digital commerce solutions for retail, restaurant, and digital banking. The company operates in three reportable segments: Retail, Restaurants, and Digital Banking. The Retail segment provides software solutions for retailers of all sizes, enhancing operational efficiency and customer experience. The Restaurants segment offers end-to-end technology solutions for food service establishments, improving operational efficiency, and customer satisfaction, and reducing costs. The Digital Banking segment serves financial institutions with cloud-based software solutions for a fully integrated digital banking experience across channels. Revenue sources include software sales and service support within each segment.

Share on Social Networks: